Ligand profile
CIU
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_0681 — alpha/beta hydrolase fold family protein
Identifiers
Database identifiers and provenance.
- Ligand ID
CIU- PDB
1vj5- UniProt (similar protein)
P34913- Target protein
- VK055_0681
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 41.1
- −1 ≤ LogP ≤ 5 3.75
- MW ≤ 500 Da 344.2
- LogP ≤ 5 3.75
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 1
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 41.1
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1cc(ccc1NC(=O)NC2CCCCC2)Ic1cc(ccc1NC(=O)NC2CCCCC2)I
InChI=1S/C13H17IN2O/c14-10-6-8-12(9-7-10)16-13(17)15-11-4-2-1-3-5-11/h6-9,11H,1-5H2,(H2,15,16,17)InChI=1S/C13H17IN2O/c14-10-6-8-12(9-7-10)16-13(17)15-11-4-2-1-3-5-11/h6-9,11H,1-5H2,(H2,15,16,17)
AQTBUVAFYDVTFD-UHFFFAOYSA-NAQTBUVAFYDVTFD-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00561
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand CIU →
- PDB RCSB structure 1vj5 →
- UniProt UniProt P34913 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CIU”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_0681.
PDB 98
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).